Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis

Clinical trial NCT03963375 · COMPLETED

Trial details

NCT number: NCT03963375
Sponsor: Gregory Wu
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis Multiple Sclerosis, Relapsing-Remitting

Start date: 2019-10-28
Primary completion: 2025-05-27
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.